EcoFactor, Inc. v. Google LLC (US Court of Appeals) November 27, 2024

WASHINGTON—AdvaMed, the Medtech Association, the world’s largest medtech trade association, representing over 650 medical technology innovators, has filed an amicus curiae brief in the Walker v. Becton, Dickinson and Company and C. R. Bard, Inc. case now before the Georgia Court of Appeals, urging the Court to reverse a trial court ruling that allowed unreliable expert testimony on ethylene oxide (EtO) exposure.

This comment letter from AdvaMed responds to the OSTP’s Request for Information
on National Strategic Plan for Advanced Manufacturing (“OSTP RFI”).

Supreme Court Term in Review: Implications for the Medical Technology Industry

WASHINGTON, D.C. –  AdvaMed, the Medtech Association, today announced that its board of directors has unanimously approved revisions to the AdvaMed Code of Ethics on Interactions with Health Care Professionals.   

AdvaMed was honored to address delegates at the 12th Asia-Pacific Economic Cooperation (APEC) Business Ethics for SMEs Forum held in Seoul, Korea, on September 8-9, 2025. AdvaMed galvanized delegates from across the APEC region to advance high standard business integrity codes to ensure patients everywhere have access to the best medtech for them.

Washington, D.C.—AdvaMed, the Medtech Association, asked the US District Court for the District of Massachusetts to rule as a matter of law that independent sales agent (ISA) arrangements do not — by themselves — violate the Anti-Kickback Statute (AKS) and, accordingly, grant summary judgment in the Langer v Zimmer Biomet case.

Christopher L. White, Esq., AdvaMed’s General Counsel & Chief Policy Officer, on why this year’s legal, compliance & regulatory programming is mission-critical as medtech leaders navigate uncertainty, shifting enforcement priorities, and a rapidly changing global legal landscape.